Development of maculopapular exanthem in a COVID‐19 patient

Motohashi, Iori; Takano, Tomonori; Ie, Kenya; Hashimoto, Yuki; Akino, Saki; Okuse, Chiaki

doi:10.1111/1346-8138.15579

Cited by 3 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Japan, 12 cases of COVID‐19‐associated viral eruptions have been reported thus far. 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 These reports are summarized in Table S2 . The total number of cases of COVID‐19‐associated viral eruption in Japan was 33, including the 21 patients we saw.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Cutaneous manifestations of coronavirus disease 2019 patients in Japan

Tamai

Sakamoto

Goto

et al. 2022

The Journal of Dermatology

View full text Add to dashboard Cite

Some patients with coronavirus disease 2019 (COVID‐19) develop skin manifestations. There may be regional and racial differences in the frequency and type of COVID‐19‐associated skin manifestations. There are, however, few reports on skin manifestations in COVID‐19 patients in Asia, including Japan. We retrospectively investigated the frequency, type, and clinical course of skin manifestations in Japanese patients with COVID‐19. From 22 February 2020 to 16 August 2021, 738 Japanese patients (median age 59 years, 55% male) with laboratory‐confirmed COVID‐19 on polymerase chain reaction or antigen tests were admitted to our hospital. We mainly admitted patients with mild to moderate severity who had symptoms such as cough, fever, and oxygen demand but did not require mechanical ventilation. A total of 2.8% (21/738) of the COVID‐19 patients treated at our hospital were diagnosed with viral eruptions caused by COVID‐19. Of the 21 patients, 19 developed erythematous papules, and two developed urticaria. There were no cases of pernio‐like lesions, known as COVID toes. The median duration from the onset of other COVID‐19 symptoms to the development of skin manifestations was 9 days. This study revealed that approximately 2–3% of Japanese patients with COVID‐19 developed COVID‐19‐associated viral eruptions, most of which were erythematous papules.

show abstract

Section: Resultsmentioning

confidence: 99%

“…In Japan, 12 cases of COVID-19-associated viral eruptions have been reported thus far. 4,5,[6][7][8][9][10][11][12] These reports are summarized in Table S2.…”

Section: Review Of Literaturementioning

confidence: 99%

Cutaneous manifestations of coronavirus disease 2019 patients in Japan

Tamai

Sakamoto

Goto

et al. 2022

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

Novelli

Motta

Santis

et al. 2021

Journal of Autoimmunity

View full text Add to dashboard Cite

Maculopapular skin eruptions associated with Covid‐19: A systematic review

Shams

Rathore²,

Anvekar

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

In this systematic review, we anticipated in summarizing clinical features, histopathological hallmarks, and possible pathology behind the maculopapular skin eruptions occurring in Covid-19 patients. A literature search was executed using MEDLINE/ PubMed and Embase databases for articles published till 20 November 2020. All eligible articles including observational studies, case reports, and case series reporting the maculopapular skin lesion in Covid-19 patients were included. Data were obtained for 354 Covid-19 patients presenting with maculopapular lesions from 40 studies. The mean age of these patients was 53 years, and with 42% of them being male. These maculopapular lesions differed considerably in terms of distribution and appearance, ranging from diffuse erythematous maculopapular lesions to scattered erythematous macules coalescing into papules to maculopapular lesions in plaques. The mean duration of the lesion was 8 days. These lesions were frequently localized on trunks and extremities. Superficial perivascular dermatitis with lymphocytic infiltrate was a histopathological hallmark of these lesions. As these skin lesions may have a possible association with diagnosis, management, prognosis, and severity of the disease, all health practitioners need to be well acquainted with these Covid-19 skin lesions. Also, in the middle of this worldwide pandemic, early identification of this eruption may help manage this infection's further spread.

show abstract

Development of maculopapular exanthem in a COVID‐19 patient

Abstract: of FDE assisted in the safe continuation of PD-1i. Besides autoimmune skin blistering disorders, worsening of FDE can also be a differential diagnosis in patients with bulla formation.

Cited by 3 publications

References 4 publications

Cutaneous manifestations of coronavirus disease 2019 patients in Japan

Cutaneous manifestations of coronavirus disease 2019 patients in Japan

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

Maculopapular skin eruptions associated with Covid‐19: A systematic review

Contact Info

Product

Resources

About